Exelixis, Inc. (EXEL) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $14.41B, a trailing price-to-earnings ratio of 16.6 and a free-cash-flow yield of 5.2%. Over the most recent reported fiscal year, revenue grew 7.0% and free cash flow per share grew 40.0%.